Epizyme welcome to Ipsen
Epizyme welcome to Ipsen
Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.
Epizyme welcome to Ipsen
- 12 August 2022 - 1 mins read

Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.
Related Stories

20 November 2023
1 mins read
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics

10 November 2023
2 mins read
Ipsen’s mission to accelerate innovation in oncology

10 November 2023
1 mins read
Examining the European Pharma legislation: EFPIA publishes the Dolon Report

03 November 2023
0 mins read
Capital Markets Day 2023

27 October 2023
1 mins read
Ipsen is officially recognized as a great place to work worldwide

23 October 2023
1 mins read
2023 year to date and third-quarter sales results

27 July 2023
1 mins read
A strong first half of 2023

20 July 2023
1 mins read
Winner of Ipsen’s golden ticket announced as newest resident of Biolabs Hôtel Dieu

07 July 2023
1 mins read
David Loew, Philippe Lopes Fernandes inaugurate Biolabs – Hôtel Dieu

02 June 2023
1 mins read